Granules India informs about company updates

22 Aug 2019

US FDA has completed inspection of the facility of Granules Pharmaceuticals, Inc., a wholly-owned foreign subsidiary of the Company located in Chantilly, Virginia, USA on 21St August 2019 with two minor observations. This is a pre-approval inspection for seven products filed from this facility. Granules Pharmaceuticals, Inc will respond to these observations within the stipulated time period.

The above information is a part of company’s filings submitted to BSE.

Related Granules India Ltd. Links:

Granules India Share Price

345.85 -2.90 (-0.83%) Mar 08, 18:37
1 Year Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 614.85
Dr. Reddys Lab 4490.20
Lupin 1050.45
Piramal Enterprises 1917.10
Cadila Healthcare 446.10
View more..
Sensex vs Granules India
Puchho Befikar
SEBI Registered: Investment Adviser - INA000013323

Callback